Literature DB >> 15001445

Indirect intracoronary delivery of adenovirus encoding adenylyl cyclase increases left ventricular contractile function in mice.

David M Roth1, N Chin Lai, Mei Hua Gao, Jeffery D Drumm, Jesus Jimenez, James R Feramisco, H Kirk Hammond.   

Abstract

We performed indirect intracoronary delivery of adenovirus vectors in mice and explored techniques including hypothermia and pharmacological means to increase cardiac gene transfer. Mice were maintained in a normothermic state or cooled to 25 degrees C. The aorta or both the pulmonary artery and aorta were clamped while a needle was advanced into the left ventricular cavity to deliver adenovirus vectors encoding enhanced green fluorescent protein (EGFP) or murine adenylyl cyclase type VI (AC(VI)) with saline, sodium nitroprusside, acetylcholine, or serotonin. Clamping was maintained for 30 s (normothermia) or 2 min (25 degrees C) after adenovirus administration. Mice were killed 7 or 21 days later, and hearts were examined for EGFP expression. Compared with clamping the aorta alone and with no cooling, gene transfer was increased as follows: 1) 1.3-fold with hypothermia to extend dwell time; 2) 4.5-fold by clamping the aorta and the pulmonary artery; 3) 11.4-fold with nitroprusside administration; 4) 11.8-fold with serotonin addition, and 5) 14.3-fold with acetylcholine delivery. Gene expression remained substantial at 21 days, and no significant inflammatory response was seen. Efficacy of the method was tested by performing gene transfer of adenovirus encoding AC(VI). Fourteen days after gene transfer, hearts isolated from mice that received adenovirus encoding AC(VI) showed increased contractile function. Indirect intracoronary delivery of adenovirus vectors in mice is associated with efficient cardiac gene transfer and increased left ventricular function after AC(VI) gene transfer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15001445     DOI: 10.1152/ajpheart.01009.2003

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  18 in total

Review 1.  Prospects for gene transfer for clinical heart failure.

Authors:  T Tang; M H Gao; H Kirk Hammond
Journal:  Gene Ther       Date:  2012-04-26       Impact factor: 5.250

Review 2.  Regenerative therapies in electrophysiology and pacing.

Authors:  Michael R Rosen; Peter R Brink; Ira S Cohen; Peter Danilo; Richard B Robinson; Amy B Rosen; Matthias J Szabolcs
Journal:  J Interv Card Electrophysiol       Date:  2008-03-25       Impact factor: 1.900

Review 3.  Targeted gene therapy for the treatment of heart failure.

Authors:  Kleopatra Rapti; Antoine H Chaanine; Roger J Hajjar
Journal:  Can J Cardiol       Date:  2011 May-Jun       Impact factor: 5.223

4.  A kinase interacting protein (AKIP1) is a key regulator of cardiac stress.

Authors:  Mira Sastri; Kristofer J Haushalter; Mathivadhani Panneerselvam; Philip Chang; Heidi Fridolfsson; J Cameron Finley; Daniel Ng; Jan M Schilling; Atsushi Miyanohara; Michele E Day; Hiro Hakozaki; Susanna Petrosyan; Antonius Koller; Charles C King; Manjula Darshi; Donald K Blumenthal; Sameh Saad Ali; David M Roth; Hemal H Patel; Susan S Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-14       Impact factor: 11.205

5.  Comparative cardiac gene delivery of adeno-associated virus serotypes 1-9 reveals that AAV6 mediates the most efficient transduction in mouse heart.

Authors:  Carmela Zincarelli; Stephen Soltys; Giuseppe Rengo; Walter J Koch; Joseph E Rabinowitz
Journal:  Clin Transl Sci       Date:  2010-06       Impact factor: 4.689

6.  Concomitant intravenous nitroglycerin with intracoronary delivery of AAV1.SERCA2a enhances gene transfer in porcine hearts.

Authors:  Ioannis Karakikes; Lahouaria Hadri; Kleopatra Rapti; Dennis Ladage; Kiyotake Ishikawa; Lisa Tilemann; Geng-Hua Yi; Charlotte Morel; Judith K Gwathmey; Krisztina Zsebo; Thomas Weber; Yoshiaki Kawase; Roger J Hajjar
Journal:  Mol Ther       Date:  2012-01-03       Impact factor: 11.454

7.  Gene therapy for myocardial infarction-associated congestive heart failure: how far have we got?

Authors:  H Kirk Hammond; Tong Tang
Journal:  Dialog Cardiovasc Med       Date:  2009

Review 8.  Unanticipated signaling events associated with cardiac adenylyl cyclase gene transfer.

Authors:  Mei Hua Gao; H Kirk Hammond
Journal:  J Mol Cell Cardiol       Date:  2011-02-23       Impact factor: 5.000

9.  Disruption of protein kinase A localization using a trans-activator of transcription (TAT)-conjugated A-kinase-anchoring peptide reduces cardiac function.

Authors:  Hemal H Patel; Lora L Hamuro; Byeong Jo Chun; Yoshitaka Kawaraguchi; Alexander Quick; Brian Rebolledo; Juniper Pennypacker; Jackie Thurston; Natalia Rodriguez-Pinto; Christopher Self; Gary Olson; Paul A Insel; Wayne R Giles; Susan S Taylor; David M Roth
Journal:  J Biol Chem       Date:  2010-06-26       Impact factor: 5.157

10.  Comparison of adeno-associated virus serotypes and delivery methods for cardiac gene transfer.

Authors:  Hongfei Fang; Ngai Chin Lai; Mei Hua Gao; Atsushi Miyanohara; David M Roth; Tong Tang; H Kirk Hammond
Journal:  Hum Gene Ther Methods       Date:  2012-08       Impact factor: 2.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.